Zepbound vs Saxenda
Side-by-side on efficacy, form, dosing, side effects, and 2026 cash-pay and insurance pricing.
| Zepbound | Saxenda | |
|---|---|---|
| Active ingredient | Tirzepatide | Liraglutide |
| Form | Injection | Injection |
| Avg weight loss | ~22.5% | ~5–8% |
| Cash price / mo | $299–$499 | $299/mo (generic) |
| FDA for obesity | Approved | Approved |
Zepbound is substantially more effective (22.5% vs 5–8%) but much more expensive than generic liraglutide. For most insured patients, Zepbound is the right choice. Saxenda (or its generics) is the budget path and the only option for patients aged 12–17.
Who wins on what
Different eras of GLP-1 therapy
Saxenda (liraglutide 3 mg daily) was the first modern GLP-1 for obesity, approved in 2014 and delivering ~5–8% weight loss. Zepbound (tirzepatide weekly) launched a decade later with roughly 3x the weight-loss efficacy.
On raw efficacy, it's not close. Saxenda survives in 2026 for three specific reasons: pediatric approval (12–17), generic availability, and patients who already respond well to liraglutide.
Cost
Generic liraglutide 3 mg: $299–$499/month cash. Brand Saxenda: ~$1,349 list. Zepbound: $349 via LillyDirect Self Pay, $0–$25 with commercial insurance + savings card.
The cash case for generic liraglutide is strongest when insurance doesn't cover either drug and the patient wants a brand-equivalent FDA-approved option. For insured patients, Zepbound is often similar or cheaper out-of-pocket.
When Saxenda still makes sense
Teens 12–17 (Saxenda is the only GLP-1 FDA-approved in this group). Uninsured patients rejecting both LillyDirect and compounded options. Patients with proven Saxenda response who prefer to continue.
For most adults in 2026, Zepbound is the stronger first-line choice.
Frequently asked questions
Can teenagers take Zepbound?
Not yet. Zepbound is not FDA-approved for patients under 18 as of April 2026. Pediatric trials are ongoing. Saxenda (liraglutide 3 mg) is the only GLP-1 FDA-approved for adolescents 12–17.
Is generic liraglutide as good as Saxenda?
Yes — FDA-approved generics must demonstrate bioequivalence to the brand. The difference is cost, not clinical effect.
Should I switch from Saxenda to Zepbound?
For most adults who can access Zepbound (insurance or LillyDirect cash), switching typically produces substantial additional weight loss. Timing varies; your prescriber can manage the transition without a washout.
Not sure which is right for you? Take the Sherpa Matcher — it accounts for your goals, budget, and insurance in 60 seconds.